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AbStrAct
Progressive facial hemiatrophy (PFH) is a rare condition characterized by the slow, progressive appearance of a unilateral 
facial atrophy that affects the skin, subcutaneous tissue, muscle and bone. We report the case of a 60-year-old female 
patient whose cutaneous symptoms commenced in 1987 in the form of a purplish erythema on the left side of her face 
and neck, which subsequently remitted giving rise to an indurated region in the left maxillary region. Since 1995 until 
the present day, she has developed facial hemiatrophy on the left side accompanied by progressive osseous reabsorption 
of the upper maxilla and left mandible with atrophy of soft tissue. The association of the onset of PFH with progressive 
osteolysis of the maxilla has not been previously reported in an adult patient.
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INtrODUctION
Progressive facial hemiatropy (PFH), or Parry-Romberg’s 
syndrome, is a rare condition of unknown aetiology charac-
terized by the slow and progressive appearance of unilateral 
facial atrophy that affects the skin, subcutaneous tissue, 
muscle and bone (1-3). Hemilateral extension to the trunk 
and members has been reported in isolated cases (1,4). It 
frequently commences in the first or second decade of life, 
progresses at a variable rhythm and stabilizes within a period 
of between 2-10 years .
The osseous lesions described in PFH are variable and are 
strictly related to the age at which the condition appears 
(4). When the condition commences after the age of  15 
years, the lesions are considered to appear exclusively in 
soft tissue (5).
We present a late appearing case of  PFH with impor-
tant associated osseous lesions involving maxilla and left 
hemimandible,that we have had the opportunity to study 
in recent years. As we know, it is the first case reported with 
this particular development.
cASE rEPOrt
65-year-old female patient, the outstanding event in whose 
personal case history is having been operated on due to a 
hypophysial adenoma in 1979 and subsequent radioterapy. 
The cutaneous manifestations commenced in 1987 in the 
form of purplish erythemal maculae and some telangiestasia 
on the left side of the face and neck. The histopathological 
study showed a moderate inflammatory perivascular in-
filtrate, predominantly limphocytic. This process evolved 
spontaneously in 2-3 years towards an indurated area, with 
the color of  normal skin, localized in the left maxillary 
region. A cutaneous biopsy found a flattened epidermis, 
without rete ridge, and an increase in collagen throughout 
the entire thickness of the dermis. This surrounded the hair 
follicles and eccrine glands, which were found to be com-
pressed by the fibrosis. Perivascular infiltration of lympho-
cytes and plasmatic cells was also observed. These findings 
led us to diagnose morphea. Since 1995 until the present 
day, the patient has slowly and progressively developed an 
atrophy on the left side of her face. This started off  in the 
form of a depressed area in the maxillary region with atro-
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phied, waxy-yellowish skin and accentuated folds. A slight 
upward turning of the corner of the mouth was observed 
on the affected side. The left half  of both lips presented 
a decrease in thickness that resulted in poor occlusion of 
the orifice of the mouth with exposal of some teeth (Fig. 
1). The anatomopathological study showed atrophy of the 
epidermis and replacement of the subcutaneous tissue by 
collagen. The diverse analyses carried out throughout the 
process, such as Hemogram, VSG, Hematic Biochemistry, 
ANA and anti-DNA, Complement, Immunoglobulins and 
Cryoglobulins, were either normal or negative. The serology 
for Borrelia burgdorferi was negative.
The patient was simultaneously assessed in the Maxillo-
facial Surgery Service from 1994 onwards due to lack of 
cicatrisation of the left maxillary alveolar layers after dental 
exodontia carried out one year previously. The orthopanto-
mographies (Fig. 2) showed progressive reabsorption of 
the left upper maxilla and of the left mandible (body and 
ascending ramus). Facial CT (1998 and 2002) evidenced 
importante atrophy of afected bone end soft tissue. Last CT 
showed a pathologic mandibular fracture , resolved without 
surgery (Fig. 3). Bone biopsies were inespecific. Nowadays, 
the patient has a good quality of life.
Fig. 1. Depressed area in the left maxillary region and 
accentuated folds. Upward turning of the corner of 
the mouth was observed on the affected side.
Fig. 2. Orthopantomographs showed progressive left 
mandibular reabsorption. Upper: Year 1994; Lower: 
Year 2002.
Fig. 3. CT (1998) with axial 
(A) and coronal (B) cuts show-
ing bimaxilar and soft tissues 
atrophy. Tridimensional 2002 
CT (C and D) showed a patho-
logic mandibular fracture and 
severe left side bimaxillar 
atrophy.
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DIScUSSION
The diagnosis of PFH in our case is based on the clinical 
and histopathological history, presenting atrophy of the 
skin and subcutaneous tissue as the most significant facts. 
Its onset was both delayed (in a 45-year-old patient) and 
insidious with purplish-erythemal blemishes that evolved 
to an indurate plaque suggestive of morphea, finally deve-
loping into facial hemiatrophy. 
The relationship between localized scleroderma and PFH 
is the subject of  debate. Some authors consider lineal 
scleroderma to be an abortive form of PFH (6), and even 
the same disorder (7), while others suggest that an overlap 
exists between them (8). Sakuraoka et al. (9) reported two 
types of clinical presentation of PFH: the first, in the form 
of  non adherent depressions on the cheek without any 
other cutaneous manifestations; and in contrast to this, a 
second indurated form with marked dermal fibrosis, often 
associated with scleroderma in other areas of the body. For 
these authors, both types would represent one and the same 
connective tissue disorder, similar to localized or generalized 
scleroderma and whose differences in clinical presentations 
would depend rather on the region of the dermis affected. 
Our case would be included in this second form of presen-
tation of PFH.
The osseous lesions described in PFH are variable and are 
strictly related to the age at which the condition appears 
(2,4). When onset occurs in children younger than 5 years 
of  age, it is frequent to find the frontoorbitozygomatic 
area affected, whereas when onset is late in occurring, the 
skeletal changes take place preferentially in the lower third 
of the face (4). The most frequently reported osseous le-
sions consist of maxillary and mandibulary hypoplasia, in 
all dimensions, with deviation of the mid-line of the face 
towards the affected side (4). The mandibulary body may 
be shorter than normal, presenting deficient verticality and 
a delay in the development of the mandibular angle (3). 
Spontaneous fractures of the mandible have been reported 
(10). It is common to observe eruptive delays and alterations 
in dental development accompanying these changes, with 
dental hypoplasia both in the maxillary and mandibular 
arch (3,4). 
When the onset of the condition occurs at a later age, after 
the age of 15 years, the lesions are considered to appear 
exclusively in the soft tissue (4.5). The present study reports 
a case of PFH developed over an area of prior induration 
in an adult patient with substantial progressive atrophy of 
the maxillomandibular area and accompanying osseous 
lesions of the osteolytic type. This peculiar association of 
atrophy of the soft tissues with progressive osteolysis of the 
maxillae has not been previously reported.
The aetiology of the PFH is unknown, but many authors 
associate this entity and Lyme disease, supported on isolated 
cases (11). In our case the serology for Borrelia burgdorferi 
was negative, so this cause was excluded.
The treatment is usually based on reposition of adipose 
tissue that was lost due to atrophy. Autogenous fat grafts, 
cartilage grafts, silicon injections and prostheses, bovine 
collagen and inorganic implants are some alternatives to 
esthetic correction of the atrophy. However, these treatment 
modalities resolve just momentarily the good appearance, 
whereas all the structure projected in the cosmetic surgery is 
lost with time, due to gravity action, and the patient needs a 
new intervention The cosmetic treatment is just recommen-
ded when the illness stops its evolution (12).
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